GPR41 and GPR43 regulate CD8+ T cell priming during herpes simplex virus type 1 infection

Front Immunol. 2024 Mar 8:15:1332588. doi: 10.3389/fimmu.2024.1332588. eCollection 2024.

Abstract

Naïve CD8+ T cells need to undergo a complex and coordinated differentiation program to gain the capacity to control virus infections. This not only involves the acquisition of effector functions, but also regulates the development of a subset of effector CD8+ T cells into long-lived and protective memory cells. Microbiota-derived metabolites have recently gained interest for their influence on T cells, but much remains unclear about their role in CD8+ T cell differentiation. In this study, we investigated the role of the G protein-coupled receptors (GPR)41 and GPR43 that can bind microbiota-derived short chain fatty acids (SCFAs) in CD8+ T cell priming following epicutaneous herpes simplex virus type 1 (HSV-1) infection. We found that HSV-specific CD8+ T cells in GPR41/43-deficient mice were impaired in the antigen-elicited production of interferon-gamma (IFN-γ), tumour necrosis factor-alpha (TNF-α), granzyme B and perforin, and failed to differentiate effectively into memory precursors. The defect in controlling HSV-1 at the site of infection could be restored when GPR41 and GPR43 were expressed exclusively by HSV-specific CD8+ T cells. Our findings therefore highlight roles for GPR41 and GPR43 in CD8+ T cell differentiation, emphasising the importance of metabolite sensing in fine-tuning anti-viral CD8+ T cell priming.

Keywords: CD8+ T cells; GPR41; GPR43; MPEC; SCFA; differentiation; microbiota.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD8-Positive T-Lymphocytes / metabolism
  • Fatty Acids, Volatile / metabolism
  • Herpes Simplex* / metabolism
  • Herpesvirus 1, Human* / metabolism
  • Interferon-gamma / metabolism
  • Mice

Substances

  • Fatty Acids, Volatile
  • Interferon-gamma

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The authors declare that this study received funding from Merck KgaA, Darmstadt, Germany (350th Anniversary Research Grant, http://researchgrants.merckgroup.com). The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication. This work was furthermore supported by the International Research Training Group (IRTG2168) funded by the German Research Council and the University of Melbourne. DT is supported by the National Health and Medical Research Council Australia (NHMRC, GNT2003395 and GNT2008990). TG and SB are supported by Investigator Fellowships from the NHMRC (APP1194482, APP2008408 respectively).